Back

Relation of gut microbiota-dependent TMAO with aortic atherosclerosis: prognostic implication for patients with stroke

29 August 2017 (14:54 - 15:12)
Organised by:
Congress Presentation Part of: Integration of old and new prognostic biomarkers in patients with cardiovascular disease Biomarkers ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Arash Haghikia

University Hospital St. Josef, Bochum (Germany)

4 More presentations in this session

Presentation thumbnail
State of the art: integration of old and new prognostic biomarkers in patients with cardiovascular disease
Professor M. Kavousi (Rotterdam, NL)
Presentation thumbnail
Iron deficiency independently and strongly predicts adverse outcome in patients with acute coronary syndrome - first report on the prospective relevance of iron deficiency
Doctor S. Schaefer (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
The impact of serum amolyoid A on long term mortality (12 years) in patients with carotid atherosclerosis.
Associate Professor M. Hoke (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Evidence-based medicine: challenges in implementation of new prognostic tools.
Professor M. Piepoli (San Donato Milanese, IT)
Slides Video

Access the full session

Session thumbnail
Integration of old and new prognostic biomarkers in patients with cardiovascular disease

The Event

Event poster

ESC Congress 2017

29 August 2017 14:54 CET
You may be interested in
thumbnail
Congress Presentation
In-hospital dynamics of trimethylamine N-oxide (TMAO) predicts major adverse cardiovascular events in patients with acute myocardial infarction
25 April 2024
thumbnail
Webinar
Inflammation in cardiovascular disease and classification of human atherosclerotic plaques according to underlying biology and clinical presentation
10 September 2024
thumbnail
Congress Presentation
Circulating metabolites are biomarker candidates for stroke risk prediction as assed in a europe-wide population cohort (biomarcare)
27 August 2023
thumbnail
Congress Presentation
Role of the gut microbiome for the cholesterol lowering effect of atorvastatin
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources